Search alternatives:
significant protective » significant positive (Expand Search), significant potential (Expand Search), significant proteomic (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
protective decrease » progressive decrease (Expand Search)
significant protective » significant positive (Expand Search), significant potential (Expand Search), significant proteomic (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
protective decrease » progressive decrease (Expand Search)
-
501
-
502
Demographic and ocular features.
Published 2025“…</p><p>Results</p><p>In the PCG group, H<sub>2</sub>O<sub>2</sub> and MDA levels were notably higher than in controls (p < 0.001, <i><i>p</i> </i>= 0.020), while TAS levels were significantly lower (p = 0.043). Adjusting for age and gender, the serum TAS (OR = 0.07, 95% CI 0.01–0.85, <i><i>p</i></i> = 0.037), H<sub>2</sub>O<sub>2</sub> (OR = 1.21, 95% CI 1.09–1.35, <i><i>p</i></i> = 0.001) and MDA (OR = 1.17, 95% CI 1.00–1.34, <i><i>p</i></i> = 0.034) were determined to be independent risk/protective factors for PCG. …”
-
503
Machine learning model to diagnose PCG.
Published 2025“…</p><p>Results</p><p>In the PCG group, H<sub>2</sub>O<sub>2</sub> and MDA levels were notably higher than in controls (p < 0.001, <i><i>p</i> </i>= 0.020), while TAS levels were significantly lower (p = 0.043). Adjusting for age and gender, the serum TAS (OR = 0.07, 95% CI 0.01–0.85, <i><i>p</i></i> = 0.037), H<sub>2</sub>O<sub>2</sub> (OR = 1.21, 95% CI 1.09–1.35, <i><i>p</i></i> = 0.001) and MDA (OR = 1.17, 95% CI 1.00–1.34, <i><i>p</i></i> = 0.034) were determined to be independent risk/protective factors for PCG. …”
-
504
ROC curves of TAS + SOD + MDA to diagnose PCG.
Published 2025“…</p><p>Results</p><p>In the PCG group, H<sub>2</sub>O<sub>2</sub> and MDA levels were notably higher than in controls (p < 0.001, <i><i>p</i> </i>= 0.020), while TAS levels were significantly lower (p = 0.043). Adjusting for age and gender, the serum TAS (OR = 0.07, 95% CI 0.01–0.85, <i><i>p</i></i> = 0.037), H<sub>2</sub>O<sub>2</sub> (OR = 1.21, 95% CI 1.09–1.35, <i><i>p</i></i> = 0.001) and MDA (OR = 1.17, 95% CI 1.00–1.34, <i><i>p</i></i> = 0.034) were determined to be independent risk/protective factors for PCG. …”
-
505
Protective effect of phosphoenolpyruvate carboxykinase 1 on inflammation and fibrotic progression of IgA nephropathy
Published 2025“…In experiments with SV40-transformed mouse glomerular mesangial cells (MCs), PCK1 and PPARγ protein expression levels were significantly decreased in polymeric IgA1 (pIgA1)-stimulated MCs, which contrasts with the increased expression of inflammatory and fibrotic factors. …”
-
506
Primers for qPCR.
Published 2024“…In contrast, melatonin supplementation blocked the PGAM5-mPTP axis and thus decreased cell death, providing a protective advantage to hepatocytes in I/R. …”
-
507
S1 Raw data -
Published 2024“…In contrast, melatonin supplementation blocked the PGAM5-mPTP axis and thus decreased cell death, providing a protective advantage to hepatocytes in I/R. …”
-
508
The chemical structure of melatonin.
Published 2024“…In contrast, melatonin supplementation blocked the PGAM5-mPTP axis and thus decreased cell death, providing a protective advantage to hepatocytes in I/R. …”
-
509
The funnel plot of mortality rate.
Published 2025“…Compared with the control group (placebo), high-dose intravenous iron significantly decreased the rate of postoperative red blood cell transfusion among patients undergoing cardiac surgery (risk ratio 0.69, 95% confidence interval [CI] 0.52–0.91, P = 0.009, I<sup>2</sup> = 61%, n = 975, certainty of evidence: moderate). …”
-
510
General Characteristics of the Included Studies.
Published 2025“…Compared with the control group (placebo), high-dose intravenous iron significantly decreased the rate of postoperative red blood cell transfusion among patients undergoing cardiac surgery (risk ratio 0.69, 95% confidence interval [CI] 0.52–0.91, P = 0.009, I<sup>2</sup> = 61%, n = 975, certainty of evidence: moderate). …”
-
511
pHI for net status.
Published 2025“…</p><p>Conclusion</p><p>Both physical integrity and bioefficacy of LLINs declined significantly within 18 months. The findings demonstrate that not all nets in the field offer maximum protection by this time point, calling for net care education and further evaluation of PBO-LLINs especially in pyrethroid-resistant regions.…”
-
512
Combined net integrity PBO and LLINs-PLOS1.
Published 2025“…</p><p>Conclusion</p><p>Both physical integrity and bioefficacy of LLINs declined significantly within 18 months. The findings demonstrate that not all nets in the field offer maximum protection by this time point, calling for net care education and further evaluation of PBO-LLINs especially in pyrethroid-resistant regions.…”
-
513
Factors affecting pyrethroid-LLINs integrity.
Published 2025“…</p><p>Conclusion</p><p>Both physical integrity and bioefficacy of LLINs declined significantly within 18 months. The findings demonstrate that not all nets in the field offer maximum protection by this time point, calling for net care education and further evaluation of PBO-LLINs especially in pyrethroid-resistant regions.…”
-
514
Factors associated with mosquito net integrity.
Published 2025“…</p><p>Conclusion</p><p>Both physical integrity and bioefficacy of LLINs declined significantly within 18 months. The findings demonstrate that not all nets in the field offer maximum protection by this time point, calling for net care education and further evaluation of PBO-LLINs especially in pyrethroid-resistant regions.…”
-
515
LLINs knockdown performance over time.
Published 2025“…</p><p>Conclusion</p><p>Both physical integrity and bioefficacy of LLINs declined significantly within 18 months. The findings demonstrate that not all nets in the field offer maximum protection by this time point, calling for net care education and further evaluation of PBO-LLINs especially in pyrethroid-resistant regions.…”
-
516
Factors affecting PBO-LLINs integrity.
Published 2025“…</p><p>Conclusion</p><p>Both physical integrity and bioefficacy of LLINs declined significantly within 18 months. The findings demonstrate that not all nets in the field offer maximum protection by this time point, calling for net care education and further evaluation of PBO-LLINs especially in pyrethroid-resistant regions.…”
-
517
Net bioefficacy data.
Published 2025“…</p><p>Conclusion</p><p>Both physical integrity and bioefficacy of LLINs declined significantly within 18 months. The findings demonstrate that not all nets in the field offer maximum protection by this time point, calling for net care education and further evaluation of PBO-LLINs especially in pyrethroid-resistant regions.…”
-
518
House structure and status.
Published 2025“…</p><p>Conclusion</p><p>Both physical integrity and bioefficacy of LLINs declined significantly within 18 months. The findings demonstrate that not all nets in the field offer maximum protection by this time point, calling for net care education and further evaluation of PBO-LLINs especially in pyrethroid-resistant regions.…”
-
519
LLINs hole positions over time.
Published 2025“…</p><p>Conclusion</p><p>Both physical integrity and bioefficacy of LLINs declined significantly within 18 months. The findings demonstrate that not all nets in the field offer maximum protection by this time point, calling for net care education and further evaluation of PBO-LLINs especially in pyrethroid-resistant regions.…”
-
520
Table_3_Combinatorial protection of cochlear hair cells: not too little but not too much.docx
Published 2024“…All compounds were added at a dosage below that required for significant protection in the assay, and only this single dose was then employed. …”